MedPath
FDA Approval

Kerendia

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
September 1, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Finerenone(20 mg in 1 1)

Manufacturing Establishments3

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Bayer AG

Bayer Healthcare Pharmaceuticals Inc.

314398484

Sharp Corporation

Bayer Healthcare Pharmaceuticals Inc.

143696495

AMPAC Fine Chemicals, Rancho Cordova

Bayer Healthcare Pharmaceuticals Inc.

073903937

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Kerendia

Product Details

NDC Product Code
50419-541
Application Number
NDA215341
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
July 9, 2021
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
Code: DE2O63YV8RClass: ACTIBQuantity: 20 mg in 1 1
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT

Kerendia

Product Details

NDC Product Code
50419-540
Application Number
NDA215341
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
July 9, 2021
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
Code: DE2O63YV8RClass: ACTIBQuantity: 10 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath